Intelligent Bio Solutions (INBS) Total Liabilities (2019 - 2025)

Intelligent Bio Solutions has reported Total Liabilities for 7 years, with the latest figure at $5.4 million in Q2 2025.

• For the quarter ending Q2 2025, Total Liabilities fell 2.85% year-over-year to $5.4 million; the trailing twelve-month figure through Jun 2025 stood at $5.4 million (down 2.85% YoY), and the FY2025 full-year result was $5.4 million, down 2.85% from the prior year.
• Total Liabilities for Q2 2025 stood at $5.4 million, up from $4.6 million in the prior quarter.
• The five-year high for Total Liabilities was $7.8 million in Q4 2022, with the low at $1.6 million in Q1 2021.
• Average Total Liabilities over 5 years is $5.6 million, with a median of $5.6 million recorded in 2021.
• Peak annual rise in Total Liabilities reached 338.3% in 2021, while the deepest fall reached 73.2% in 2021.
• Tracing INBS's Total Liabilities over 5 years: stood at $5.2 million in 2021, then soared by 49.97% to $7.8 million in 2022, then slipped by 27.13% to $5.7 million in 2023, then decreased by 21.02% to $4.5 million in 2024, then climbed by 21.32% to $5.4 million in 2025.
• The last three Total Liabilities figures came in at $5.4 million (Q2 2025), $4.6 million (Q1 2025), and $4.5 million (Q4 2024), per Business Quant data.

Peer Comparison